188.20
-1.40
(-0.74%)
At close: January 31 at 5:27:10 PM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
15,539,000.00
15,868,000.00
14,210,000.00
13,319,000.00
Total Liabilities Net Minority Interest
6,564,000.00
6,804,000.00
5,824,000.00
6,047,000.00
Total Equity Gross Minority Interest
8,975,000.00
9,064,000.00
8,386,000.00
7,272,000.00
Total Capitalization
11,853,000.00
11,602,000.00
10,357,000.00
9,512,000.00
Common Stock Equity
8,975,000.00
9,064,000.00
8,386,000.00
7,271,000.00
Capital Lease Obligations
161,000.00
140,000.00
135,000.00
110,000.00
Net Tangible Assets
-511,000.00
-1,092,000.00
54,000.00
-666,000.00
Working Capital
828,000.00
192,000.00
886,000.00
768,000.00
Invested Capital
11,852,000.00
11,824,000.00
10,374,000.00
9,908,000.00
Tangible Book Value
-511,000.00
-1,092,000.00
54,000.00
-666,000.00
Total Debt
3,038,000.00
2,900,000.00
2,123,000.00
2,747,000.00
Net Debt
2,016,000.00
1,861,000.00
725,000.00
1,301,000.00
Share Issued
194,505.66
194,505.66
194,505.66
194,505.66
Ordinary Shares Number
189,776.57
189,594.90
189,173.88
189,025.44
Treasury Shares Number
4,729.09
4,910.76
5,331.78
5,480.22
12/31/2020 - 5/15/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1AEA.SG argenx SE
635.00
+2.42%
1AE.SG argenx SE
637.80
+1.75%
ARGX.VI argenx SE
642.80
+1.61%
LVTX LAVA Therapeutics N.V.
0.9800
+3.62%
ARGX argenx SE
655.13
-1.58%
CORT Corcept Therapeutics Incorporated
66.92
-4.26%
PPCB Propanc Biopharma, Inc.
9.00
0.00%
AKRO Akero Therapeutics, Inc.
54.08
-2.31%